BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 13680220)

  • 1. Central atypical papillomas of the breast: a clinicopathological study of 119 cases.
    MacGrogan G; Tavassoli FA
    Virchows Arch; 2003 Nov; 443(5):609-17. PubMed ID: 13680220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision.
    Renshaw AA; Derhagopian RP; Tizol-Blanco DM; Gould EW
    Am J Clin Pathol; 2004 Aug; 122(2):217-21. PubMed ID: 15323138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary lesions of the breast: To excise or observe?
    Khan S; Diaz A; Archer KJ; Lehman RR; Mullins T; Cardenosa G; Bear HD
    Breast J; 2018 May; 24(3):350-355. PubMed ID: 28845569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology of breast papillary neoplasms: Community hospital experience.
    Vdovenko AA
    Ann Diagn Pathol; 2020 Dec; 49():151605. PubMed ID: 32920473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of the clinicopathological characteristics and prognosis in 674 cases of breast intraductal papillary tumor].
    Wang WY; Wang X; Gao JD; Wang J; Liu JQ; Wang X; Zhao DB
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):429-433. PubMed ID: 28635232
    [No Abstract]   [Full Text] [Related]  

  • 6. Intraductal papillomas on core biopsy can be upgraded to malignancy on subsequent excisional biopsy regardless of the presence of atypical features.
    Shiino S; Tsuda H; Yoshida M; Jimbo K; Asaga S; Hojo T; Kinoshita T
    Pathol Int; 2015 Jun; 65(6):293-300. PubMed ID: 25801805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma.
    Page DL; Salhany KE; Jensen RA; Dupont WD
    Cancer; 1996 Jul; 78(2):258-66. PubMed ID: 8674001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
    Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
    Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excision is indicated for intraductal papilloma of the breast diagnosed on core needle biopsy.
    Jaffer S; Nagi C; Bleiweiss IJ
    Cancer; 2009 Jul; 115(13):2837-43. PubMed ID: 19402174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillomatous breast lesions with atypical columnar cell features.
    de Boer M; Verschuur-Maes AHJ; Moelans C; van Diest PJ
    J Clin Pathol; 2023 Apr; 76(4):228-233. PubMed ID: 36693714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast papillomas with atypical ductal hyperplasia: a clinicopathologic study.
    Raju U; Vertes D
    Hum Pathol; 1996 Nov; 27(11):1231-8. PubMed ID: 8912836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.
    Tse GM; Tan PH; Lui PC; Gilks CB; Poon CS; Ma TK; Law BK; Lam WW
    J Clin Pathol; 2007 Mar; 60(3):315-20. PubMed ID: 16698948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of intraductal papillomas of the breast: an analysis of 129 cases and their outcome.
    Ahmadiyeh N; Stoleru MA; Raza S; Lester SC; Golshan M
    Ann Surg Oncol; 2009 Aug; 16(8):2264-9. PubMed ID: 19484312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranodal papillary epithelial proliferations: a local process with a spectrum of morphologies and frequent association with papillomas in the breast.
    Boulos FI; Granja NM; Simpson JF; O'Malley FP; Saadeldine MM; Page DL; Sanders ME
    Am J Surg Pathol; 2014 Mar; 38(3):383-8. PubMed ID: 24525508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillary lesions of the breast with and without atypical ductal hyperplasia: can we accurately predict benign behavior from core needle biopsy?
    Agoff SN; Lawton TJ
    Am J Clin Pathol; 2004 Sep; 122(3):440-3. PubMed ID: 15362376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A useful immunohistochemical approach to evaluate intraductal proliferative lesions of the breast and to predict their prognosis.
    Omi Y; Yamamoto T; Okamoto T; Obara T; Kobayashi M
    Histol Histopathol; 2011 Jan; 26(1):79-86. PubMed ID: 21117029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraductal Papilloma with Benign Pathology on Breast Core Biopsy: To Excise or Not?
    Tatarian T; Sokas C; Rufail M; Lazar M; Malhotra S; Palazzo JP; Hsu E; Tsangaris T; Berger AC
    Ann Surg Oncol; 2016 Aug; 23(8):2501-7. PubMed ID: 26960929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myoepithelial cells in solid variant of intraductal papillary carcinoma of the breast: a potential diagnostic pitfall and a proposal of an immunohistochemical panel in the differential diagnosis with intraductal papilloma with usual ductal hyperplasia.
    Moritani S; Ichihara S; Kushima R; Okabe H; Bamba M; Kobayashi TK; Hattori T
    Virchows Arch; 2007 May; 450(5):539-47. PubMed ID: 17377808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathologic and immunohistochemical study of 187 cases of intraductal papillary neoplasm of breast].
    Zhang H; Xiong Y; Zhang S; Zhang Y; Wang YH; Li T
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):726-31. PubMed ID: 22336153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical follow-up and clinical presentation of 142 breast papillary lesions diagnosed by ultrasound-guided core-needle biopsy.
    Rizzo M; Lund MJ; Oprea G; Schniederjan M; Wood WC; Mosunjac M
    Ann Surg Oncol; 2008 Apr; 15(4):1040-7. PubMed ID: 18204989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.